HIGHLIGHTS
- who: B surface antigen and colleagues from the (UNIVERSITY) have published the paper: Risk Strati fi cation for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection, in the Journal: (JOURNAL)
- what: The medical records of the study subjects were retrieved for analysis. The authors comprehensively collected the data on immunosuppressants and analyzed the dosages and durations of corticosteroid use. The analysis demonstrates that receiving a peak steroid dose u226520 mg/day of prednisolone equivalent u22654 weeks in maintenance had a major impact on risk of HBV reactivation. The study demonstrates an . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.